Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$67.45 - $85.63 $3.01 Million - $3.83 Million
-44,698 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$65.1 - $93.59 $589,024 - $846,802
-9,048 Reduced 16.83%
44,698 $3.29 Million
Q4 2020

Feb 02, 2021

BUY
$48.36 - $77.92 $245,668 - $395,833
5,080 Added 10.44%
53,746 $3.9 Million
Q3 2020

Nov 05, 2020

BUY
$36.14 - $51.99 $63,642 - $91,554
1,761 Added 3.75%
48,666 $2.32 Million
Q2 2020

Aug 12, 2020

BUY
$22.98 - $48.57 $618,391 - $1.31 Million
26,910 Added 134.58%
46,905 $1.97 Million
Q1 2020

May 12, 2020

BUY
$20.44 - $41.21 $239,148 - $482,157
11,700 Added 141.05%
19,995 $540,000
Q4 2019

Jan 27, 2020

BUY
$17.74 - $39.52 $147,153 - $327,818
8,295 New
8,295 $319,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.45B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.